Medifast
MED
#9100
Rank
A$0.19 B
Marketcap
A$17.49
Share price
-0.24%
Change (1 day)
-19.41%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2025 (TTM): -A$8.68 Million

According to Medifast's latest financial reports the company's current earnings are A$0.42 Billion. In 2024 the company made an earning of A$4.04 Million a decrease over its 2023 earnings that were of A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$8.68 Million-314.51%
2024 A$4.04 M-97.72%
2023 A$0.17 B-31.61%
2022 A$0.25 B-14.56%
2021 A$0.30 B61.25%
2020 A$0.18 B47.36%
2019 A$0.12 B31.82%
2018 A$97.01 M74.26%
2017 A$55.67 M47.56%
2016 A$37.73 M-6.36%
2015 A$40.29 M-16.28%
2014 A$48.12 M2%
2013 A$47.18 M44.4%
2012 A$32.67 M-16.75%
2011 A$39.25 M-12.14%
2010 A$44.67 M63.85%
2009 A$27.26 M136.71%
2008 A$11.51 M35.74%
2007 A$8.48 M-142.56%
2006 -A$19.95 Million-448.43%
2005 A$5.72 M35.62%
2004 A$4.22 M-16.51%
2003 A$5.05 M
2000 A$0.68 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 2,697.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
A$0.11 B-1,550.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$15.51 Million 93.60%๐Ÿ‡บ๐Ÿ‡ธ USA